BD Reports Third Quarter Fiscal 2023 Financial Results

Continues Strong Performance and Progress Toward Achieving BD 2025 Strategy; Advances Innovation Pipeline and Receives Clearance for Updated BD Alaris™...

Related Keywords

Ukraine ,United States ,Russia ,Dublin ,Ireland ,China ,Troy Kirkpatrick ,Francesca Demartino ,Tom Polen ,Companies To Work ,Business Revenue Growth Including Divested ,Exchange Commission ,Business Organic Revenue Growth ,Bd Life Sciences Revenues ,Business Revenues ,European Union Medical Device Regulation ,Revenue Growth ,A Noteworthy Company In Diversityinc ,Medication Delivery Solutions ,Business Revenue Growth Net Of Divested ,Catheter Solutions ,Business Revenue ,Image Technology ,Linkedin ,Bd Life Sciences ,Diagnostics Solutions ,Solutions Revenues ,Embecta Corp ,Business Inorganic Contribution To Revenue Growth ,Medication Management Solutions ,Continues Strong Performance ,Progress Toward Achieving ,Advances Innovation Pipeline ,Receives Clearance ,Infusion System ,Surgical Instrumentation ,Stick Hospital ,Premium Sample Preparation System ,Integrated Diagnostics Solutions ,Informatics Solution ,Pharmaceutical Systems ,Partner Badge ,Healthcare Industry Resilience Collaborative ,Best Place ,Disability Inclusion ,Equality Index ,World Report ,Quarter Fiscal ,Months Ended June ,Diluted Earnings ,Organic Revenue Growth ,Vascular Access Management ,Pharmacy Automation ,Integrated Diagnostic Solutions ,Total Modular Track ,Peripheral Intervention ,Critical Care ,Advanced Repair ,Peripheral Vascular Disease ,Targeted Temperature Management ,Digital Endoscope System ,Full Year Fiscal ,Surgical Implementation ,Diabetes Care ,Devices Regulations ,Investor Relations ,Public Relations ,Diagnostic Testing ,Base Organic Revenue Growth ,Business Revenue Decline Attributable ,Divested Business Post ,Business Revenue Growth Net ,Business Inorganic Contribution ,Business Organic Revenue ,Only Diagnostic Testing ,Foreign Currency ,Base Business Revenue ,Bd Becton ,Ickinson And Company ,